Walk into any supplement store today, and you'll see gummies everywhere. The industry reports sound amazing, with the global gummy supplement market projected to approach $48 billion by 2028 and double-digit annual growth. Everyone wants them. But after years of manufacturing these products, I can tell you the real story looks nothing like those market reports.
The real story sits on production floors, in formulation labs, and in quality control testing that never makes it into glossy market analyses.
The Production Speed Problem Nobody Talks About
Gummies are painfully slow to make compared with every other supplement format.
A high-speed rotary tablet press cranks out hundreds of thousands of tablets an hour, and capsule fillers keep pace in the same range. Gummy production? You're looking at maybe 20,000 to 60,000 pieces per hour on a typical depositing line.
A single mogul line for gummies runs into seven figures. Then you need climate-controlled rooms, specialized drying space, and far more square footage than you'd need for tablets or capsules. And it still produces a fraction of the output.
Sure, gummies sell at a premium over tablets and deliver better margins. But that doesn't help if you can't make enough of them to meet demand.
What's strangling the market is production capacity.
Right now, if you want to launch a gummy supplement, good luck finding a manufacturer with open capacity. Most are booked solid for months. The brands that got in early locked up production at the old prices. Everyone else is paying more and waiting four to six months from formulation to finished product.
This is a structural constraint on how fast the market can grow, no matter what consumer demand looks like.
The Formulation Reality Check
There's a hard reality: you can't just turn any supplement into a gummy. It doesn't work that way. A large share of popular supplement ingredients either don't dissolve properly or can't be loaded into a gummy matrix at levels that do anything. The chemistry doesn't cooperate. Iron brings a metallic taste and oxidation problems, concentrated fish oils separate out of a water-based matrix, and many botanicals are too bitter to mask in a sweet chew.
Take a typical multivitamin tablet with 30 or 40 different ingredients. Try to make that as a gummy? You'll be lucky to fit 12 to 15 ingredients at meaningful amounts. The gelatin or pectin base has hard limits on what it can hold.
When analysts say the gummy market will eat into the tablet and capsule markets, they're missing a key point. A huge chunk of supplements can't be made as gummies. The addressable market is far smaller than the total supplement market.
The Dose Dilemma
Each gummy weighs between 2 and 5 grams, but only 20 to 40% of that can be your active ingredients. The rest is sweeteners, the gelling agent, water, and stabilizers, all the stuff that makes it a gummy instead of a horse pill.
Want to deliver 400 mg of magnesium glycinate? That's 4 to 6 gummies. Need 1000 mg of vitamin C? Better get ready to chew 5 to 8 gummies. High-dose fish oil? Forget about it unless you want customers eating a dozen gummies a day.
The format has built-in limitations that no amount of consumer demand can overcome. You can make pieces larger, but past about 5 grams they become awkward to chew and harder to dose evenly.
Quality Control Costs They Don't Mention
Testing gummies costs more than testing capsules or tablets, because these products are harder to keep stable.
The Moisture Nightmare
Gummies pull moisture from the air. They're like little sponges sitting in your bottle, constantly exchanging water with their environment. This causes all sorts of problems:
- Weight can vary several percent batch to batch, more than tablets typically do
- Active ingredient concentration drifts as moisture content changes
- Texture goes wrong, turning too hard, too soft, or too sticky
- Higher moisture means higher risk of bacteria or mold
To deal with this, we run stability testing for 12 to 18 months with multiple checkpoints. That runs into five figures per product just in development. Launch a line of six gummy products? You're looking at six-figure testing costs before you sell a single bottle.
At KorNutra, we've invested in extended stability programs. Why? Because a gummy that looks and tastes great when it ships but turns into a sticky mess three months later destroys your brand faster than any bad review.
The Regulatory Gap That's Closing
Right now, gummies get a pass on some of the stricter requirements that apply to tablets. Tablets have to meet tight weight uniformity standards under USP's uniformity-of-dosage-units chapter. Gummies have more wiggle room because they're regulated as dietary supplements. Supplement gummies fall under 21 CFR Part 111, the dietary supplement cGMP rule, which focuses on process controls and finished-product specs rather than the pharmacopeial uniformity limits written for drug tablets.
That advantage won't last forever. As the market grows and problems pop up, regulations will tighten. The smart manufacturers are already running pharmaceutical-grade controls. The ones cutting corners? They're going to face expensive retrofits when the rules change.
What's Driving Growth
Forget the trend pieces about millennials and Instagram. Three real factors are pushing this market forward.
The Swallowing Problem
Up to 40% of American adults report difficulty swallowing pills, and older adults are more susceptible. This is a medical issue called dysphagia.
As the population ages, gummies aren't a nice-to-have anymore. They're necessary. That's a much more reliable growth driver than fleeting consumer trends, but it also demands a completely different level of manufacturing quality.
We're making medical nutrition products that happen to look like candy. The standards, documentation, and process controls are night and day different.
The Plant-Based Shift
Most gummies have used gelatin, which comes from animal collagen. But consumer demand for vegan options is pushing the industry toward pectin, extracted from fruit peels and cores. Pectin has already overtaken gelatin in new launches. More than half of gummies introduced in 2023 used pectin, and pectin now leads the gelling-agent segment.
But switching from gelatin to pectin isn't simple. You can't swap one ingredient for another. The entire process changes:
- Different acidity levels (pH 3.0 to 3.5 instead of 4.0 to 5.0)
- Different drying times and temperatures
- Different ingredients to keep them from getting too hard
- Different coatings to prevent sticking
We've invested millions in dual-capability lines that can handle both gelatin and pectin because we see where this is headed. But that kind of investment creates a divide in the industry: large manufacturers with flexibility, and smaller shops that have to pick one or the other.
Shelf Life Economics
The difference between an 18-month and a 24-month shelf life completely changes your business model.
It affects your inventory costs, how much product gets returned or wasted, whether you can ship in summer heat, and whether you can sell internationally. Six months doesn't sound like much, but it's the difference between profit and loss for many brands.
Getting to that 24-month shelf life at room temperature requires:
- Pharmaceutical-grade climate control while manufacturing
- Premium moisture-barrier packaging, which costs several times what a regular bottle does
- Preservative systems that don't make your product taste like chemicals
- Constant monitoring and testing
The manufacturers who crack this code win big. But the investment required limits how many new players can enter the market.
The Absorption Question
People assume gummies absorb better than pills. It's messier than that.
The sugar in gummies can speed gastric emptying, which changes how quickly some nutrients are absorbed compared with timed-release capsules. But gummies make it easier for people to remember to take their supplements consistently, and consistency often matters more than perfect absorption per dose.
As consumers get savvier, brands will need to deliver both convenience and optimal bioavailability. We're already working on solutions: gummies with oil-based centers, layered designs with different release rates, hybrid formats that combine the best of multiple delivery systems.
These innovations aren't simple. They require expertise across multiple types of manufacturing. That's exactly the kind of technical capability that will separate winners from also-rans in the next phase of market growth.
Supply Chain Weak Points
Limited Ingredient Sources
Both gelatin and pectin come from relatively few suppliers. Price swings are bigger, and disruptions hit harder than with most supplement ingredients.
Gelatin comes from animal processing, which faces ethical scrutiny and religious dietary restrictions. Porcine gelatin, the most common grade, is off-limits for halal and kosher markets, which pushes brands toward bovine gelatin or pectin. Pectin is a byproduct of fruit processing, mainly citrus and apples. Neither supply chain can scale infinitely without years of planning.
The Sweetener Challenge
Most gummies use sugar, corn syrup, or a mix of alternative sweeteners. As brands try to make healthier formulations with less sugar, they run into technical problems:
- Alternative sweeteners can crystallize during storage
- They affect texture in unpredictable ways
- Many leave aftertastes that are hard to mask
- Some reduce shelf stability
Every reformulation cycle adds months and costs that slow down new product launches.
Automation Is Closing the Throughput Gap
The capacity picture is not standing still. Starch-free depositors have pushed gummy throughput up in the last two years. Baker Perkins lists a single-head Flexi depositor at 125,000 pieces an hour and a two-head machine at 250,000, and its ServoForm Flexi+ line is rated up to 1,000 kilograms an hour. That begins to close the gap with capsule and tablet lines, without the starch handling and long drying rooms a mogul system needs.
The new equipment doesn't make gummies cheap to produce. These systems carry a higher capital cost and demand tighter process control, which favors manufacturers who already run dual-capability lines and can fund the upgrade. Nutritional Outlook's 2026 reporting notes that new, smaller contract manufacturers have added capacity, but that capacity is still limited and quality is uneven. The constraint is shifting from raw output to capital and expertise, which changes who wins without removing the barrier.
Where the Market Goes Next
Based on what we're seeing in product development, the next wave of growth will come from innovations that solve current limitations.
Hybrid delivery systems will pair gummy convenience with the dosing capacity of capsules or tablets. Imagine getting a gummy for taste and compliance plus a small capsule for the nutrients that don't work in gummy form, both in one daily pack.
Advanced formulation techniques will push active ingredient loading from today's 20 to 40% up to 50 to 60% through nano-emulsions and novel gelling systems. We're testing these now, and they work.
Targeted-release gummies with special coatings or multi-layer structures will deliver ingredients to specific parts of your digestive system. This solves the bioavailability concerns while keeping all the format benefits people love.
These innovations demand serious R&D investment and manufacturing upgrades. The companies making those investments now will dominate the next cycle.
What This Means If You're Launching a Gummy Brand
Market size numbers make great pitch decks, but they're almost meaningless if you don't understand the manufacturing realities.
The Questions That Matter
Can you secure production capacity? With manufacturers booked months out, your launch date depends on production partnerships, not market opportunity. Start conversations a year or more before you need finished products.
Does your formula work as a gummy? Not every supplement translates to this format. Before you spend a dime on branding or packaging, verify that your target ingredients can be effectively delivered in gummy form at reasonable serving sizes.
Can you afford the real costs? Premium packaging, climate control, extensive testing: it all adds up. A gummy that falls apart after 12 months torches your brand reputation faster than any marketing campaign can build it. Factor in these costs before committing to the format.
Do you have enough capital? Gummy development takes 16 to 24 weeks from concept to finished goods. Gummy minimums sit at the top of the range among dosage forms because of the specialized equipment and longer production cycles. That runs above the capital requirement for capsules or tablets.
The Defensibility Factor
The complexity and capital requirements of gummy manufacturing create natural barriers to entry that many brands miss. Once you nail quality formulations with stable manufacturing relationships, competitors can't easily displace you.
This cuts both ways. Get in early with solid execution, and you build defensible competitive advantage. Show up late to a crowded market, and you're fighting for limited capacity at premium prices against entrenched players.
The Real Growth Picture
Market projections assume linear growth, unlimited manufacturing capacity, stable raw material prices, and a consistent regulatory environment.
Reality looks different. Growth gets constrained by capacity, quality requirements keep escalating, ingredient supplies fluctuate, and regulations tighten.
The market will still grow, but not smoothly. Success will concentrate around manufacturers who can solve formulation challenges, stability issues, and scalability problems all at once.
Manufacturing Is Your Competitive Edge
The gummy supplement market represents real opportunity. But treating manufacturing as a cost center is a fatal mistake. In this market, manufacturing excellence is your primary competitive advantage.
Focus on formulations that work with the format's natural strengths instead of fighting against its limitations. Choose ingredients and doses that suit gummy delivery rather than forcing therapeutic levels into incompatible forms.
Lock down production partnerships early with clear capacity commitments. The manufacturers with available slots and technical expertise are the real gatekeepers of market entry.
Build products that stay stable across their entire shelf life. A gummy that changes texture, color, or potency frustrates customers no matter how good it was on day one.
Run realistic financial models that account for higher minimums, longer development timelines, premium packaging, and extensive testing. Underfunded gummy launches fail more often than the products themselves.
At KorNutra, we've spent years developing the technical capabilities, process controls, and quality systems needed to manufacture gummies that meet pharmaceutical standards while remaining commercially viable. The investment was substantial, but it positions us to serve brands that understand manufacturing complexity determines market success.
The Bottom Line
Consumer demand for gummy supplements is real, and manufacturing capacity to meet it is constrained. Quality requirements are escalating and regulatory scrutiny is increasing.
The brands that win will be those who view gummy manufacturing as a technical discipline requiring expertise, investment, and patience, not another product format to add to the line.
The market is enormous and growing. It's also far more complex than those headline numbers suggest. Understanding what happens in the production facility is how you turn market opportunity into revenue and market share.